跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
ALEMBIC-DEFERASIROX (TYPE J) - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
ALEMBIC-DEFERASIROX (TYPE J)
Authorized
STANDARD
ALEMBIC-DEFERASIROX (TYPE J)
ALEMBIC PHARMACEUTICALS LIMITED
🇨🇦 Health Canada
Approval Date
Mar 30, 2026
Approval ID
063b5b5461004df2
Company
ALEMBIC PHARMACEUTICALS LIMITED
Type
Standard
Approval Details
Approval Id
063b5b5461004df2
Drug Approval Canada Name
ALEMBIC-DEFERASIROX (TYPE J)
Product Name
ALEMBIC-DEFERASIROX (TYPE J)
Status
Approved
Status Date
2026-01-29
Drug Class
Human
Dosage Form
Tablet
Route Of Administration
Oral
Schedule
PRESCRIPTION
Ahfs
64:00.00
Atc Original
V03AC03 DEFERASIROX
Aig Number
0151733006
Company Name
ALEMBIC PHARMACEUTICALS LIMITED
Company Address
Alembic Road Vadodara Gujarat India 390003
Company Detail Path
/organization/alembic-pharmaceuticals-limited
Company Information
Pharmaceutical Company Name
ALEMBIC PHARMACEUTICALS LIMITED
Country Name
India
Province Name
Gujarat
City Name
vadodara,gujarat,country_in
Address
Alembic Road Gorwa
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Mar 30, 2026
Approval ID
063b5b5461004df2
Type
Standard
Back to Health Canada Approvals